CNB-CSIC's NEWTON Biotwins Project Selected by 'la Caixa' Foundation

The project aims to develop personalized medicine through biotwins, virtual replicas of patients.

The NEWTON Biotwins Project, led by the Spanish National Research Council (CSIC) and the National Centre for Biotechnology (CNB), has been selected for funding by the 'la Caixa' Foundation.

The project focuses on developing biotwins, virtual replicas of patients, to improve personalized medicine and treatment outcomes.

The funding will enable the project team to advance their research and develop biotwins for various diseases, with the goal of improving patient care and treatment.